| For: | Barone M, Viggiani MT, Losurdo G, Principi M, Leo AD. Systematic review: Renin-angiotensin system inhibitors in chemoprevention of hepatocellular carcinoma. World J Gastroenterol 2019; 25(20): 2524-2538 [PMID: 31171895 DOI: 10.3748/wjg.v25.i20.2524] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v25/i20/2524.htm |
| Number | Citing Articles |
| 1 |
Atamjit Singh, Preet Mohinder Singh Bedi. The Renin Angiotensin System in Cancer, Lung, Liver and Infectious Diseases. Advances in Biochemistry in Health and Disease 2023; 25 doi: 10.1007/978-3-031-23621-1_18
|
| 2 |
Yee Hui Yeo, Manal Abdelmalek, Seema Khan, Cynthia A. Moylan, Luz Rodriquez, Augusto Villanueva, Ju Dong Yang. Current and emerging strategies for the prevention of hepatocellular carcinoma. Nature Reviews Gastroenterology & Hepatology 2025; 22(3) doi: 10.1038/s41575-024-01021-z
|
| 3 |
Shi-Dong Lu, Lin Li, Xin-Min Liang, Wu Chen, Fu-Li Chen, Lang-Lin Fan, Bhavesh K. Ahir, Wan-Guang Zhang, Jian-Hong Zhong. Updates and advancements in the management of hepatocellular carcinoma patients after hepatectomy. Expert Review of Gastroenterology & Hepatology 2019; 13(11) doi: 10.1080/17474124.2019.1684898
|
| 4 |
Xinrong Zhang, Grace Lai‐Hung Wong, Terry Cheuk‐Fung Yip, Yee‐Kit Tse, Lilian Yan Liang, Vicki Wing‐Ki Hui, Huapeng Lin, Guan‐Lin Li, Jimmy Che‐To Lai, Henry Lik‐Yuen Chan, Vincent Wai‐Sun Wong. Angiotensin‐converting enzyme inhibitors prevent liver‐related events in nonalcoholic fatty liver disease. Hepatology 2022; 76(2) doi: 10.1002/hep.32294
|
| 5 |
Michele Barone. Angiotensin-converting enzyme 2 and AMPK/mTOR pathway in the treatment of liver fibrosis: Should we consider further implications?. World Journal of Gastroenterology 2024; 30(18): 2391-2396 doi: 10.3748/wjg.v30.i18.2391
|
| 6 |
Yuqing Li, Boxuan Wang, Dan Zhang, Ying Xin, Xingyu Wang. Hypertension associated with systemic therapy for hepatocellular carcinoma and management strategies. Frontiers in Pharmacology 2026; 17 doi: 10.3389/fphar.2026.1780200
|
| 7 |
Ruixing Zhang, Hongtao Yin, Mengdi Yang, Jinjin Liu, Donghu Zhen, Zheng Zhang. Advanced progress of the relationship between renin–angiotensin–aldosterone system inhibitors and cancers. Journal of Hypertension 2024; 42(11) doi: 10.1097/HJH.0000000000003836
|
| 8 |
Manoj Kumar Kashyap, Anjali Bhat, Divya Janjua, Rashmi Rao, Kulbhushan Thakur, Arun Chhokar, Nikita Aggarwal, Joni Yadav, Tanya Tripathi, Apoorva Chaudhary, Anna Senrung, Alok Chandra Bharti. Angiotensin. 2023; doi: 10.1016/B978-0-323-99618-1.00019-2
|
| 9 |
Kyoko Oura, Asahiro Morishita, Joji Tani, Tsutomu Masaki. Antitumor Effects and Mechanisms of Metabolic Syndrome Medications on Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma 2022; doi: 10.2147/JHC.S392051
|
| 10 |
Adriana Albini, Douglas M. Noonan, Paola Corradino, Francesca Magnoni, Giovanni Corso. The Past and Future of Angiogenesis as a Target for Cancer Therapy and Prevention. Cancer Prevention Research 2024; 17(7) doi: 10.1158/1940-6207.CAPR-24-0085
|
| 11 |
Zhou-wei Xu, Na-na Liu, Xing-yu Wang, Bai-cheng Ding, Hai-feng Zhang, Ying Li, Wu-yi Sun, Wei Wei. Effect of PLC-β1/CaM signaling pathway mediated by AT1R on the occurrence and development of hepatocellular carcinoma. Cancer Cell International 2021; 21(1) doi: 10.1186/s12935-021-02261-8
|
| 12 |
Mary S. McGrath, Brian J. Wentworth. The Renin–Angiotensin System in Liver Disease. International Journal of Molecular Sciences 2024; 25(11) doi: 10.3390/ijms25115807
|
| 13 |
Moudhi Almutlaq, Abir Abdullah Alamro, Hassan S. Alamri, Amani Ahmed Alghamdi, Tlili Barhoumi. The Effect of Local Renin Angiotensin System in the Common Types of Cancer. Frontiers in Endocrinology 2021; 12 doi: 10.3389/fendo.2021.736361
|
| 14 |
Roy X. Wang, Marina Serper, Tamar H. Taddei, David E. Kaplan, Nadim Mahmud. The Association Between Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Exposure and Key Cirrhosis-Related Outcomes. American Journal of Gastroenterology 2025; 120(5) doi: 10.14309/ajg.0000000000002976
|
| 15 |
In-Jeong Cho, Jeong-Hun Shin, Mi-Hyang Jung, Chae Young Kang, Jinseub Hwang, Chang Hee Kwon, Woohyeun Kim, Dae-Hee Kim, Chan Joo Lee, Si-Hyuck Kang, Ju-Hee Lee, Hack-Lyoung Kim, Hyue Mee Kim, Iksung Cho, Hae-Young Lee, Wook-Jin Chung, Sang-Hyun Ihm, Kwang Il Kim, Eun Joo Cho, Il-Suk Sohn, Sungha Park, Jinho Shin, Sung Kee Ryu, Jang Young Kim, Seok-Min Kang, Myeong-Chan Cho, Wook Bum Pyun, Ki-Chul Sung. Antihypertensive Drugs and the Risk of Cancer: A Nationwide Cohort Study. Journal of Clinical Medicine 2021; 10(4) doi: 10.3390/jcm10040771
|
| 16 |
Alexander Kusnik, Nicole Hunter, Erik Rasbach, Thomas Miethke, Christoph Reissfelder, Matthias Philip Ebert, Andreas Teufel. Co-Medication and Nutrition in Hepatocellular Carcinoma: Potentially Preventative Strategies in Hepatocellular Carcinoma. Digestive Diseases 2021; 39(5) doi: 10.1159/000514277
|
| 17 |
Rong Yang, Yonggang Zhang, Xiaoyang Liao, Yi Yao, Chuanying Huang, Lixia Liu. The Relationship Between Anti-Hypertensive Drugs and Cancer: Anxiety to be Resolved in Urgent. Frontiers in Pharmacology 2020; 11 doi: 10.3389/fphar.2020.610157
|
| 18 |
José A. Carlos-Escalante, Marcela de Jesús-Sánchez, Alejandro Rivas-Castro, Pavel S. Pichardo-Rojas, Claudia Arce, Talia Wegman-Ostrosky. The Use of Antihypertensive Drugs as Coadjuvant Therapy in Cancer. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.660943
|
| 19 |
Natchaya Polpichai, Sakditad Saowapa, Pojsakorn Danpanichkul, Shu-Yen Chan, Leandro Sierra, Johanna Blagoie, Chitchai Rattananukrom, Pimsiri Sripongpun, Apichat Kaewdech. Beyond the Liver: A Comprehensive Review of Strategies to Prevent Hepatocellular Carcinoma. Journal of Clinical Medicine 2024; 13(22) doi: 10.3390/jcm13226770
|
| 20 |
Fereshteh Asgharzadeh, Reza Jafarzadeh-Esfehani, Seyed M. Hassanian, Gordon A. Ferns, Amir Avan, Majid Khazaei. Renin-angiotensin System Inhibitors and Development of Hepatocellular Carcinoma: A Systematic Review and Meta-analysis. Current Pharmaceutical Design 2020; 26(39) doi: 10.2174/1381612826666200713165018
|
| 21 |
Hiroyuki Suzuki, Naoto Fujiwara, Amit G. Singal, Thomas F. Baumert, Raymond T. Chung, Takumi Kawaguchi, Yujin Hoshida. Prevention of liver cancer in the era of next-generation antivirals and obesity epidemic. Hepatology 2026; 84(1) doi: 10.1097/HEP.0000000000001227
|
| 22 |
Harry Crane, Cameron Gofton, Ankur Sharma, Jacob George. MAFLD: an optimal framework for understanding liver cancer phenotypes. Journal of Gastroenterology 2023; 58(10) doi: 10.1007/s00535-023-02021-7
|
| 23 |
Jung-Min Yu, Wan-Ming Chen, Ming-Feng Chiang, Ming-Shun Wu, Szu-Yuan Wu. Angiotensin-Converting Enzyme Inhibitors and Hepatocellular Carcinoma Risk in Patients With Chronic Hepatitis B and Hypertension: A Nationwide Dose-Response Cohort Study. Clinical and Translational Gastroenterology 2026; doi: 10.14309/ctg.0000000000001049
|
| 24 |
Kwang Min Kim, Ji Hye Roh, Sangjin Lee, Jeong-Hyun Yoon. Do renin-angiotensin system inhibitors reduce risk for hepatocellular carcinoma?: A nationwide nested case-control study. Clinics and Research in Hepatology and Gastroenterology 2021; 45(4) doi: 10.1016/j.clinre.2020.07.015
|
| 25 |
Hai-Feng Zhang, Xiang Gao, Xuan Wang, Xin Chen, Yu Huang, Lang Wang, Zhou-Wei Xu. The mechanisms of renin–angiotensin system in hepatocellular carcinoma: From the perspective of liver fibrosis, HCC cell proliferation, metastasis and angiogenesis, and corresponding protection measures. Biomedicine & Pharmacotherapy 2021; 141 doi: 10.1016/j.biopha.2021.111868
|
| 26 |
Riccardo Nevola, Augusto Delle Femine, Valerio Rosato, Loreta Anesti Kondili, Maria Alfano, Davide Mastrocinque, Simona Imbriani, Pasquale Perillo, Domenico Beccia, Angela Villani, Rachele Ruocco, Livio Criscuolo, Marco La Montagna, Antonio Russo, Aldo Marrone, Ferdinando Carlo Sasso, Raffaele Marfella, Luca Rinaldi, Nicolino Esposito, Giuseppe Barberis, Ernesto Claar. Neoadjuvant and Adjuvant Systemic Therapies in Loco-Regional Treatments for Hepatocellular Carcinoma: Are We at the Dawn of a New Era?. Cancers 2023; 15(11) doi: 10.3390/cancers15112950
|
| 27 |
Emilie Crouchet, Shen Li, Mozhdeh Sojoodi, Simonetta Bandiera, Naoto Fujiwara, Hussein El Saghire, Shijia Zhu, Tongqi Qian, Fahmida Akter Rasha, Fabio Del Zompo, Stephen C. Barrett, Eugénie Schaeffer, Marine A. Oudot, Clara Ponsolles, Sarah C. Durand, Sarani Ghoshal, Gunisha Arora, Fabio Giannone, Raymond T. Chung, Nevena Slovic, Nicolaas Van Renne, Emanuele Felli, Patrick Pessaux, Joachim Lupberger, Nathalie Pochet, Catherine Schuster, Kenneth K. Tanabe, Yujin Hoshida, Bryan C. Fuchs, Thomas F. Baumert. Hepatocellular carcinoma chemoprevention by targeting the angiotensin-converting enzyme and EGFR transactivation. JCI Insight 2022; 7(13) doi: 10.1172/jci.insight.159254
|